Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04575090Completed
Open-label trial of simvastatin in hypercholesterolemia, sponsored by UT Southwestern Medical Center. Primary endpoint: Change in Pre- and Post-phosphocreatine Relaxation Time at 10 weeks. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04575090.